These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37820257)

  • 1. Ten-year Single Center Experience With Colistin Therapy in NICU.
    Kaya TB; Sürmeli Onay Ö; Aydemir Ö; Tekin AN
    Pediatr Infect Dis J; 2024 Feb; 43(2):165-169. PubMed ID: 37820257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colistin use in critically ill neonates: A case-control study.
    İpek MS; Aktar F; Okur N; Celik M; Ozbek E
    Pediatr Neonatol; 2017 Dec; 58(6):490-496. PubMed ID: 28501490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral colistin for the treatment of severe infections: a single center experience.
    Tanita MT; Carrilho CM; Garcia JP; Festti J; Cardoso LT; Grion CM
    Rev Bras Ter Intensiva; 2013; 25(4):297-305. PubMed ID: 24553511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study.
    Dalfino L; Puntillo F; Ondok MJ; Mosca A; Monno R; Coppolecchia S; Spada ML; Bruno F; Brienza N
    Clin Infect Dis; 2015 Dec; 61(12):1771-7. PubMed ID: 26354965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colistin Use in Patients with Extreme Renal Function: From Dialysis to Augmented Clearance.
    Aitullina A; Krūmiņa A; Svirskis Š; Purviņa S
    Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30709064
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and Safety of a Colistin Loading Dose, High-Dose Maintenance Regimen in Critically Ill Patients With Multidrug-Resistant Gram-Negative Pneumonia.
    Elefritz JL; Bauer KA; Jones C; Mangino JE; Porter K; Murphy CV
    J Intensive Care Med; 2017 Sep; 32(8):487-493. PubMed ID: 27139010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of prognosis and nephrotoxicity in patients treated with colistin in intensive care unit.
    Gunay E; Kaya S; Baysal B; Yuksel E; Arac E
    Ren Fail; 2020 Nov; 42(1):704-709. PubMed ID: 32703065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Colistin in a Neonatal Intensive Care Unit: A Cohort Study of 65 Patients.
    Çağan E; Kıray Baş E; Asker HS
    Med Sci Monit; 2017 Jan; 23():548-554. PubMed ID: 28135233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients.
    Kapoor K; Jajoo M; Dublish S; Dabas V; Gupta S; Manchanda V
    Pediatr Crit Care Med; 2013 Jul; 14(6):e268-72. PubMed ID: 23689704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.
    Zaidi ST; Al Omran S; Al Aithan AS; Al Sultan M
    J Clin Pharm Ther; 2014 Jun; 39(3):272-6. PubMed ID: 24593154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis.
    Chien HT; Lin YC; Sheu CC; Hsieh KP; Chang JS
    Int J Antimicrob Agents; 2020 Mar; 55(3):105889. PubMed ID: 31923573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study.
    Rocco M; Montini L; Alessandri E; Venditti M; Laderchi A; De Pascale G; Raponi G; Vitale M; Pietropaoli P; Antonelli M
    Crit Care; 2013 Aug; 17(4):R174. PubMed ID: 23945197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Intravenous Colistin in Very Low Birth Weight Preterm Infants.
    Ilhan O; Bor M; Ozdemir SA; Akbay S; Ozer EA
    Paediatr Drugs; 2018 Oct; 20(5):475-481. PubMed ID: 30073562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of colistin in critically ill children in a pediatric intensive care unit.
    Karbuz A; Özdemir H; Yaman A; Kocabaş BA; Odek Ç; Güriz H; Aysev AD; Çiftçi E; Kendirli T; Ateş C; İnce E
    Pediatr Infect Dis J; 2014 Jan; 33(1):e19-24. PubMed ID: 24346607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of intravenous colistin in preterm infants with nosocomial sepsis caused by Acinetobacter baumannii.
    Alan S; Yildiz D; Erdeve O; Cakir U; Kahvecioglu D; Okulu E; Ates C; Atasay B; Arsan S
    Am J Perinatol; 2014 Dec; 31(12):1079-86. PubMed ID: 24584997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity caused by colistin use in ICU: a single centre experience.
    Kilic I; Ayar Y; Ceylan İ; Kaya PK; Caliskan G
    BMC Nephrol; 2023 Oct; 24(1):302. PubMed ID: 37833622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colistin use in pediatric intensive care unit for severe nosocomial infections: experience of an university hospital.
    Karli A; Paksu MS; Karadag A; Belet N; Paksu S; Guney AK; Akgun M; Yener N; Sensoy SG
    Ann Clin Microbiol Antimicrob; 2013 Nov; 12():32. PubMed ID: 24199612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of safety and efficacy of colistin use in pediatric intensive care unit: Results from two reference hospitals and review of literature.
    Sahbudak Bal Z; Kamit Can F; Yazici P; Berna Anil A; Duyu M; Yilmaz Ciftdogan D; Nisel Yilmaz O; Cilli F; Karapinar B
    J Infect Chemother; 2018 May; 24(5):370-375. PubMed ID: 29361414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.
    Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC
    Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.